Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies

Affiliations

• ¹ Laboratory of Immunology and General Pathology, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.
• ² Endothelial Quiescence Group, Centre for Cancer Sciences, Biodiscovery Institute, School of Medicine University of Nottingham, Nottingham, United Kingdom.
• ³ Institut National de la Santé et de la Recherche Médicale, U1015, Institut Gustave Roussy, Villejuif, France.
• ⁴ Institut National de la Santé et de la Recherche Médicale, U1186, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.
• ⁵ Thumbay Research Institute of Precision Medicine, Gulf Medical University, Ajman, United Arab Emirates.
• ⁶ Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, Bari, Italy.